Coinfections in Patients Hospitalized with COVID-19: A Descriptive Study from the United Arab Emirates

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• Uddin M, Mustafa F, Rizvi TA, et al. SARS-CoV-2/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses. 2020;12(5):526. doi:10.3390/v12050526
   PubMed Web of Science ®Google Scholar
• Li XX, Zhou XN. Co-infection of tuberculosis and parasitic diseases in humans: a systematic review. Parasit Vectors. 2013;6(1):79. doi:10.1186/1756-3305-6-7923522098
   PubMed Web of Science ®Google Scholar
• Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the mulbsta score. Front Microbiol. 2019;10:2752. doi:10.3389/fmicb.2019.0275231849894
   PubMed Web of Science ®Google Scholar
• Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72(10):2097–2111. doi:10.1002/iub.235632770825
   PubMed Web of Science ®Google Scholar
• Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA, Memish ZA. Middle east respiratory syndrome coronavirus and pulmonary tuberculosis coinfection: implications for infection control. Intervirology. 2017;60(1–2):53–55. doi:10.1159/00047790828683463
   PubMed Web of Science ®Google Scholar
• Alfaraj SH, Al-Tawfiq JA, Alzahrani NA, Altwaijri TA, Memish ZA. The impact of co-infection of influenza a virus on the severity of Middle East respiratory syndrome coronavirus. J Infect. 2017;74(5):521–523. doi:10.1016/j.jinf.2017.02.00128189714
   PubMed Web of Science ®Google Scholar
• Lee N, Chan PK, Yu IT, et al. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J Clin Virol. 2007;40(4):333–337. doi:10.1016/j.jcv.2007.08.01517936066
   PubMed Web of Science ®Google Scholar
• Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505–512. doi:10.1016/j.jmii.2020.05.01332482366
   PubMedGoogle Scholar
• Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi:10.1016/j.jinf.2020.05.04632473235
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520–531. doi:10.1016/j.cmi.2020.12.01833418017
   PubMed Web of Science ®Google Scholar
• Institute CaLS. M100 Performance Standard for Antimicrobial Susceptibility Testing. 2019.
   Google Scholar
• Alhazzani W, Moller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020;48(6):e440–e469. doi:10.1097/CCM.000000000000436332224769
   PubMed Web of Science ®Google Scholar
• Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control. 2020;15:Doc35.33391970
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468. doi:10.1093/cid/ciaa53032358954
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc201041932302078
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• King CS, Sahjwani D, Brown AW, et al. Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS One. 2020;15(11):e0242651. doi:10.1371/journal.pone.024265133227024
   PubMed Web of Science ®Google Scholar
• MacLaren G, Combes A, Brodie D. What’s new in ECMO for COVID-19? Intensive Care Med. 2021;47(1):107–109. doi:10.1007/s00134-020-06284-z33180168
   PubMed Web of Science ®Google Scholar
• Roedl K, Jarczak D, Thasler L, et al. Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: a Multicentric Study in Germany. Aust Crit Care. 2021;34(2):167–175. doi:10.1016/j.aucc.2020.10.00933250401
   PubMed Web of Science ®Google Scholar
• Ebrahim SH. Lack of MERS-CoV co-infection among hospitalized COVID-19 patients in Saudi Arabia. J Epidemiol Glob Health. 2020;10(3):191. doi:10.2991/jegh.k.200819.00132954705
   PubMed Web of Science ®Google Scholar
• Karaba SM, Jones G, Helsel T, et al. Prevalence of co-infection at the time of hospital admission in COVID-19 patients, a Multicenter Study. Open Forum Infect Dis. 2021;8(1):ofaa578. doi:10.1093/ofid/ofaa57833447639
   PubMed Web of Science ®Google Scholar
• Al Jalaf M, Fadali H, Alanee R, et al. Methicillin resistant Staphylococcus aureus in emergency department patients in the United Arab Emirates. BMC Emerg Med. 2018;18(1):12. doi:10.1186/s12873-018-0164-729764376
   PubMed Web of Science ®Google Scholar
• Moubareck CA, Mouftah SF, Pal T, et al. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates. Int J Antimicrob Agents. 2018;52(1):90–95. doi:10.1016/j.ijantimicag.2018.03.00329530587
   PubMed Web of Science ®Google Scholar
• Senok A, Nassar R, Celiloglu H, et al. Genotyping of methicillin resistant Staphylococcus aureus from the United Arab Emirates. Sci Rep. 2020;10(1):18551. doi:10.1038/s41598-020-75565-w33122734
   PubMed Web of Science ®Google Scholar
• Velez Pintado M, Camiro-Zuniga A, Aguilar Soto M, et al. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Med Mycol. 2021. doi:10.1093/mmy/myab009
   Web of Science ®Google Scholar
• Antinori S, Bonazzetti C, Gubertini G, et al. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Autoimmun Rev. 2020;19(7):102564. doi:10.1016/j.autrev.2020.10256432376396
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant candida auris infections in critically ill coronavirus disease patients, India, April–July 2020. Emerg Infect Dis. 2020;26(11):2694–2696. doi:10.3201/eid2611.20350432852265
   PubMed Web of Science ®Google Scholar
• Mastrangelo A, Germinario BN, Ferrante M, et al. Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1594
   Web of Science ®Google Scholar
• Rodriguez JY, Le Pape P, Lopez O, Esquea K, Labiosa AL, Alvarez-Moreno C. Candida auris: a latent threat to critically ill patients with COVID-19. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1595
   Web of Science ®Google Scholar